- Exchanges
- BSE, NSE
- Issue
- Book building
Krsnaa Diagnostics IPO
₹987.00
+3.46% on listing
Listing-day close · NSE · 16 Aug 2021 · issue price ₹954
Krsnaa Diagnostics’ ₹1,213 crore IPO was priced at ₹954 a share. It listed on the NSE on 16 Aug 2021 and closed its first day at ₹987.00, up 3.46% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Refunds
- Shares in demat
- Listing
Issue details
- Issue size
- ₹1,213 Cr
- Fresh issue
- ₹401 Cr
- Offer for sale
- ₹812 Cr
- Lot size
- 15 shares
- Minimum investment
- ₹14,310
- Face value
- ₹5
- Registrar
- Kfin Technologies
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 35.65× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹2,996 Cr
- Promoter holding
- 29.53% → 25.57%
From the offer documents.
Listing
- Listing date
- 16 Aug 2021
- Issue price
- ₹954
- Open
- ₹1,005.55
- High
- ₹1,099.70
- Low
- ₹960.00
- Close
- ₹987.00
Listing day on the NSE. The close was +3.46% on the issue price.
KRSNAA share price todayFAQs
When did the Krsnaa Diagnostics IPO open and close?
It opened on 4 Aug 2021 and closed on 6 Aug 2021.
What was the Krsnaa Diagnostics IPO price?
The price band was ₹933–954 a share. The final issue price was ₹954.
What is the lot size and minimum investment?
One lot is 15 shares, ₹14,310 at ₹954 a share. Retail investors apply in whole lots.
How much did Krsnaa Diagnostics raise?
₹1,213 crore: ₹401 crore of new shares and ₹812 crore offered by existing shareholders.
How many times was the Krsnaa Diagnostics IPO subscribed?
35.65 times overall.
How did Krsnaa Diagnostics list?
It listed on the NSE on 16 Aug 2021 at ₹1,005.55 and closed the day at ₹987.00, up 3.46% on the ₹954 issue price.
Who is the registrar of the Krsnaa Diagnostics IPO?
Kfin Technologies handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app